Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.22.1
Segment Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2022
segment
Mar. 31, 2022
USD ($)
Mar. 22, 2022
segment
Mar. 31, 2021
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment 2   1  
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   $ 45,693   $ 55,150
Total segment operating income   (20,140)   5,764
Total operating costs and expenses   54,999   50,435
Income (loss) from operations   (9,306)   4,715
Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   45,693   55,150
Total segment operating income   3,802   13,842
Corporate, Non-Segment        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Shared-based compensation   5,657   4,870
Other corporate expenses   7,451   4,257
Total operating costs and expenses   13,108   9,127
Royalties        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   13,695   7,112
Captisol - Core        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   6,226   1,253
Captisol - COVID        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   5,896   30,019
Contract revenue        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   19,876   16,766
OmniAb Technologies | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   9,178   8,559
Total segment operating income   (6,189)   (4,604)
OmniAb Technologies | Royalties | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   263   0
OmniAb Technologies | Contract revenue | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   8,915   8,559
Ligand Core Business | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   36,515   46,591
Total segment operating income   9,991   18,446
Ligand Core Business | Royalties | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   13,432   7,112
Ligand Core Business | Captisol - Core | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   6,226   1,253
Ligand Core Business | Captisol - COVID | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   5,896   30,019
Ligand Core Business | Contract revenue | Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Total revenue   $ 10,961   $ 8,207